$HLSQ Income Statement | Understand Stock

$HLSQ

$0.21 -$0.05 (18.2%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Research and development (“R&D”) expenses, net
Amortization of intangible assets
General and administrative expenses
Gain from early lease termination
Goodwill impairment
IPR&D impairment
Long-lived assets impairment
Other long-lived assets impairment
Operating loss
Interest expenses
Financial income, net
Other expense (income)
Interest expenses
Finance expense , net
Income from change in fair value of warrants
Loss before tax
Tax expenses
Basic and diluted loss per share of Common Stock (in Dollars per share)
Weighted average number of shares of Common Stock outstanding, basic and diluted (in Shares)
Net Loss
Basic loss per share of Common Stock (in Dollars per share)
Diluted loss per share of Common Stock (in Dollars per share)
Weighted average number of shares used in computing basic loss per share of Common Stock (in Shares)
Weighted average number of shares used in computing diluted loss per share of Common Stock (in Shares)

Comments